Xin Xu

6.4k citations
191 papers · 4.5k indexed · h-index 37
Topics
Cancer-related molecular mechanisms research (23 papers)Bladder and Urothelial Cancer Treatments (19 papers)Nutritional Studies and Diet (18 papers)
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Xin Xu

186 papers receiving 4.5k citations

Peers

Xin Xu
Comparison fields: 5 of 143
  • Molecular Biology 2.7k
  • Cancer Research 1.4k
  • Oncology 798
  • Pulmonary and Respiratory Medicine 607
  • Surgery 531
Replace Massimo Sanchez with:
Massimo Sanchez Italy
Zhen Chen China
Zhiming Cai China
Yutaka Kohgo Japan
Farzin Farzaneh United Kingdom
Mónica Gumá United States
Hideaki Ito Japan
Mark Α. Zern United States
Xiaofang Wang China
Udo Jeschke Germany
Xin Xu relative to Massimo Sanchez Italy Massimo Sanchez's profile →
Citations per field
00.5×3.2×
Massimo Sanchez · 1×
Citations per year

Countries citing papers authored by Xin Xu

Since Specialization
Citations

This map shows the geographic impact of Xin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Xu more than expected).

Fields of papers citing papers by Xin Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Xu. The network helps show where Xin Xu may publish in the future.

Co-authorship network of co-authors of Xin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xin Xu. A scholar is included among the top collaborators of Xin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin Xu. Xin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 5
4 2
5 4
6 9
7 15
8 26
9
Application of Droplet Digital PCR to Detection of Mycobacterium tuberculosis and Mycobacterium leprae Infections: A Narrative Review
10
10 7
11 114
12 9
13 4
14 5
15 23
16 12
17 25
18 22
19 4
20 47

About Xin Xu

Xin Xu is a scholar working on Cancer Research, Parasitology and Molecular Biology, having authored 191 papers that have together received 4.5k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (23 papers), Bladder and Urothelial Cancer Treatments (19 papers) and Nutritional Studies and Diet (18 papers). The work is most often cited by research in Cancer Research (1.4k citations), Molecular Biology (2.7k citations) and Oncology (798 citations). Xin Xu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Liping Xie, Xiangyi Zheng, Xiao Wang, Jiangfeng Li, Xianglai Xu, Zhenghui Hu, Zhen Liang, Ben Liu, Jian Wu and Yeqing Mao. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026